(Q47347715)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Impaired verbal fluency under topiramate--evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

C E Elger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Helmstaedter

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

25 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

130-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

Topiramate: a review of its use in the treatment of epilepsy

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Differential cognitive and behavioral effects of topiramate and valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive impairments due to add-on therapy with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Effects of topiramate on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

The effects of adjunctive topiramate on cognitive function in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Topiramate dose effects on cognition: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

A meta-analytic review of verbal fluency performance following focal cortical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

A pharmacological and clinical review on topiramate, a new antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Chronic epilepsy and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Neuropsychological effects of epilepsy and antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive and behavioural assessment in clinical trials: when should they be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

Cognitive effects of levetiracetam versus topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03814.X

10.1111/J.1468-1331.2012.03814.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22827489%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference